FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

IPCALAB Share Price Discussion

IPCA Laboratories Ltd.
NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01020 | Sector: Pharmaceuticals and health care

IPCALAB Rating

4.8/5 (11 Ratings)
IPCALAB Share Price *
1,381 -16.75 (-1.2%)
* (quote may be delayed)
Find answers to all your questions on live IPCALAB message board: Is IPCALAB buy or sell? Should I buy IPCALAB shares? Why are IPCALAB shares falling? Should I invest in IPCALAB stock?

You can also check IPCALAB share price target recommended by brokerages.

IPCALAB Discussion Forum

@TTA • Reputation: 43,192

*IPCA LAB RS 14.09 CRS NSE BLOCK TRADE; FOR~ 100129 SHARES, AT RS 1407.35*
Like
reply
Reply
IPCALAB

Type
Buy
Instrument
IPCALAB
Entry Price
₹1,405
Price@Trade
₹1,390
Target Price
₹1,560
Stop Price
₹1,333
Valid Till
Apr 30, 2020 3:20 AM
Margin
₹1,405 approx for 1 Qty
Status
Active
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Apr 1 3:04 AM

Update
Trade Entered
Entry Price
₹1,405
@faujdar • Reputation: 0
Govt approves use of hydroxychloroquine with azithromycin for critical COVID-19 patients
The Ministry of Health released its revised Guidelines on Clinical Management of COVID–19 late on March 31.
www.cnbctv
Like
reply
Reply
@newsbot • Reputation: 2,602
Cadila, Ipca gain 4-9% after US allows emergency use of antimalarial drugs for COVID-19
Cadila Healthcare and Ipca Labs are prominent manufacturers of hydroxychloroquine and chloroquine in India. Both are antimalarial drugs.
Moneycontrol
Like
reply
Reply
@dreambig • Reputation: 2,084

Buy ipca labs cash
1364-1354
Sl 1344
Tgt open
Like
reply
Reply (2)
Latest replies
DREAM BIG VIEW @dreambig
Mar 31 6:23 AM

1379💸
DREAM BIG VIEW @dreambig
Mar 31 9:10 AM

1399 made high 💸💸💸
@newsbot • Reputation: 2,602
ICMR recommends use of anti-malaria drug hydroxychloriquine for treating high-risk COVID-19 patients
The high risk population who would be eligible for getting the drug include asymptomatic healthcare workers involved in the care of suspected or confirmed COVID-19 cases and asymptomatic household contacts of laboratory confirmed cases.
Moneycontrol
Like
reply
Reply
@TTA • Reputation: 43,192

*IPCA LAB RS 23.66 CRS NSE BLOCK TRADE; FOR~ 170860 SHARES, AT RS 1385*
Like
reply
Reply
@newsbot • Reputation: 2,602
Ipca Labs share price surges 12% as USFDA partially lifts import ban for chloroquine
The stock gained over 62 percent in the last 6 months and was trading with volumes of 19,120 shares
Moneycontrol
Like
reply
Reply
@albert • Reputation: 3
IPCALAB

Type
Buy
Instrument
IPCALAB
Entry Price
₹1,540
Price@Trade
₹1,530.5
Target Price
₹1,800
Stop Price
₹1,500
Valid Till
Mar 23, 2020 3:20 AM
Status
Expired before entry
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 23 8:50 AM

Update
Expired before entry
Price @ Update
₹1,381.85

IPCALAB - chart - 675781
#ipca for #Chloroquine
Like
reply
Reply
@newsbot • Reputation: 2,602
How off-the-shelf drugs are making Indian pharma firms interested in fight against COVID-19
Cipla has come forward to work with Hyderabad-based Indian Institute of Chemical Technology to develop three broadspectrum antiviral drugs to tackle novel coronavirus.
Moneycontrol
Like
reply
Reply
@dreambig • Reputation: 2,084

Keep eyes on
ipca lab buy side
Like
reply
Reply (1)
Latest replies
DREAM BIG VIEW @dreambig
Mar 20 3:23 AM

Ipca labs
Open 1332
N made high 1510
@databot • Reputation: 4,684

Motilal Oswal target on IPCALAB
Date: 25-Feb-20 Broker: Motilal Oswal Price @ Call: 1431.93 Target: 1660 Recommendation: BUY
Like
reply
Reply
IPCALAB

Type
Buy
Instrument
IPCALAB
Entry Price
₹1,336.55
Price@Trade
₹1,336.55
Target Price
₹1,855
Stop Price
₹1,220
Valid Till
Mar 12, 2021 3:20 AM
Margin
₹1,336.55 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹1,220
Net P&L
-8.72% Loss
Like
reply
Reply (2)
Latest replies

INVESTMENT BUY IPCA LAB CMP 1330 SL 1220(110) TGT 1855
TrackerBot @trackerbot
Mar 19 2:46 AM

Update
Stoploss Hit
Exit Price
₹1,220
@databot • Reputation: 4,684

Prabhudas Lilladher target on IPCALAB
Date: 02-Mar-20 Broker: Prabhudas Lilladher Price @ Call: 1432.89 Target: 1826 Recommendation: BUY
Like
reply
Reply

IPCA LAB INVESTMENT
ABOVE 1095
STOP LOSS 970
TARGET 1150 1200 1300
Like
reply
Reply
@100billionclub • Reputation: 2,152
Billion Club in IPCALAB
CARRIED CASH: BUY IPCA LAB ABV 1475

CARRIED CASH : ONCE EXIT LONG IN IPCA LAB AT 1514. BOOK PROFIT RS. 3,900
Like
reply
Reply
@100billionclub • Reputation: 2,152

CARRIED CASH: BUY IPCA LAB ABV 1475
Like
reply
Reply
@neeraj • Reputation: 1,622

IPCALAB now trading at 1440. are you expecting uptrend in it?
Like
reply
Reply

IPCALAB - 633216
For full report, u can log on to my telegram channel (link provided in my profile)
Like
reply
Reply
@newsbot • Reputation: 2,602
Market Headstart: Nifty likely to consolidate around 11,700; NIIT Tech, IPCA top buys
Trends on SGX Nifty indicate a negative opening for the broader index in India, with a 94 points loss or 0.8 percent. The Nifty futures were trading around 11,724-level on the Singaporean Exchange.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,602
Hot Stocks: Here are three buy calls for 8-11% returns in the short term
From the technical front, both Nifty and BankNifty are currently trading at crucial support levels as both the indices are now close to their 200-Days Exponential Moving Average on the daily interval.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,602
Buy Ipca Laboratories; target of Rs 1826: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1826 in its research report dated February 13, 2020.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,602
Buy Ipca Laboratories target of Rs 1590: Sharekhan
Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1590 in its research report dated February 13, 2020.
Moneycontrol
Like
reply
Reply
@databot • Reputation: 4,684

Prabhudas Lilladher target on IPCALAB
Date: 14-Feb-20 Broker: Prabhudas Lilladher Price @ Call: 1420.4 Target: 1826 Recommendation: BUY
Like
reply
Reply
@newsbot • Reputation: 2,602
Ipca Labs Consolidated December 2019 Net Sales at Rs 1,212.86 crore, up 20.55% Y-o-Y
Moneycontrol
Like
reply
Reply
IPCALAB

Type
Buy
Instrument
IPCALAB
Entry Price
₹1,505.05
Price@Trade
₹1,505.05
Target Price
₹1,570
Stop Price
₹1,480
Valid Till
Feb 14, 2020 3:20 AM
Margin
₹1,505.05 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹1,480
Net P&L
-1.66% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Feb 14 5:21 AM

Update
Stoploss Hit
Exit Price
₹1,480
@newsbot • Reputation: 2,602
Ipca Labs at record close, up 6% on strong Q3 revenue growth
Domestic formulations segment registered a 15% growth YoY at Rs 485.6 crore and exports grew 25% to Rs 585.6 crore in Q3FY20.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,602
Ipca Labs Q3 net profit up 24% to Rs 197.54cr
The company had posted a net profit of Rs 159.11 crore for the corresponding period of previous fiscal, Ipca Laboratories said in a filing to the BSE.
Moneycontrol
Like
reply
Reply
@guptan • Reputation: 2,994

IPCALAB - chart - 568230
IPCALAB
Like
reply
Reply
@guptan • Reputation: 2,994

IPCALAB - chart - 519765
IPCALAB
Like
reply
Reply
@avinashg • Reputation: 864
Here's how Ipca Laboratories turned the tide and emerged as investor favourite
Ipca, which was growing at frantic pace in the first half of this decade, lost steam in the middle due to regulatory woes.
Moneycontrol
Like
reply
Reply

IPCALAB - chart - 443968
IPCA Lab bullish Breakout > An ideal ichimoku Breakout chart
Like
reply
Reply (5)
Latest replies

I think it comes in down trend by daily basis. Weekly basis support 1060.
1200.20 is very very hard resistance.
I booked it at 1180 from 920.
Can, I take re-entry for ahead.?
The Inside Guy in IPCALAB
*Buy IPCA LAB* CMP 917 SL 800 (117) TARGET 1193...

1160 (+240) *Once book full profit*
Like
reply
Reply

Some of the growth drivers for IPCALAB are wider geographical presence; Exports remain the key growth driver, Strategic tie-up and robust pipeline to aid top-line growth,
Strong R&D and Patents.
Like
reply
Reply
@databot • Reputation: 4,684

Sharekhan target on IPCALAB
Date: 11-Nov-19 Broker: Sharekhan Price @ Call: 1092.05 Target: 1220 Recommendation: BUY
Like
reply
Reply
The Inside Guy in IPCALAB
*Buy IPCA LAB* CMP 917 SL 800 (117) TARGET 1193...

High 1119 (+200) * Investment running*
Like
reply
Reply
@databot • Reputation: 4,684

Prabhudas Lilladher target on IPCALAB
Date: 08-Nov-19 Broker: Prabhudas Lilladher Price @ Call: 1079.7 Target: 1238 Recommendation: ACCUMULATE
Like
reply
Reply
@umanath • Reputation: 563

IPCALAB - 430369

Like
reply
Reply
@guptan • Reputation: 2,994

IPCALAB - chart - 430120
IPCALAB
Like
reply
Reply

Ipca Laboratories (+5.2%) reported Q2 FY20 results. PAT was up 63.3% y/y to 193.5 crore. Revenue grew 26.9% y/y to 1,284 crore. EBITDA was up 52.5% as the margin improved 350bps y/y to 20.7%.
Like
reply
Reply
The Inside Guy in IPCALAB
*Buy IPCA LAB* CMP 917 SL 800 (117) TARGET 1193...

1020 (+100) investment running
Dream target 1200-1600-2400-3200
Like
reply
Reply
@newsbot • Reputation: 2,602
Ipca Labs Q2 PAT seen up 34% YoY to Rs. 160.2 cr: Emkay
Net Sales are expected to increase by 12.8 percent Y-o-Y (up 11.3 percent Q-o-Q) to Rs. 1,125.4 crore, according to Emkay.
Moneycontrol
Like
reply
Reply

*Buy IPCA LAB* CMP 917 SL 800 (117) TARGET 1193-1429 AND MORE... *5SHARES*
Like
reply
Reply (1)
Latest replies

IPCALAB - 432729
Ipca lab breakout Is 1200 next?
@newsbot • Reputation: 2,602
Trade Setup for Wednesday: Top 15 things to know before Opening Bell
Nifty formed a doji candle on the daily charts, which indicates indecisiveness over further direction, followed by a spinning top formation in the previous session.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,602
Trade Setup for Tuesday: Top 15 things to know before Opening Bell
While the market is logging stellar gains, analysts feel there is also a risk of consolidation.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,602
'Tata Motors above Double Bottom Neckline; may break out with a 21% upside'
Bollinger band volatility breakout can come above 11,300 marks which can add further strength to the current up move.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,602
Stocks in the news: Biocon, Petronet LNG, Hero Moto, Alkem Lab, PNB, Cipla, Torrent Pharma
Petronet LNG | Hero MotoCorp | Torrent Pharmaceuticals| Reliance Capital | HEG | PNB and Canara Bank are among stocks which are in news today.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,602
link
Avoid Aurobindo Pharma: Pritesh Mehta
Pritesh Mehta of IIFL is of the view that one may avoid Aurobindo Pharma.
Moneycontrol
Like
reply
Reply
@umanath • Reputation: 563

IPCALAB - 336750

Like
reply
Reply
  • IPCALAB - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization12,415.15
    Enterprise Value12,485.34
    Price to Earnings35.47
    Price to Book Value3.96
    Return on Capital Employed0.09
    Return on Equity0.09
    Face Value2
    Dividend YieldNA
  • IPCALAB Share Price - Technicals

    keyboard_arrow_down
    IPCALAB - 52 Week High₹1,622
    IPCALAB - 52 Week Low₹844.65
  • IPCALAB - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    2-Mar-20Prabhudas LilladherBuy1,826
    25-Feb-20Motilal OswalBuy1,660
    14-Feb-20Prabhudas LilladherBuy1,826
    11-Nov-19SharekhanBuy1,220
    8-Nov-19Prabhudas LilladherAccumulate1,238
    IPCALAB Brokerage Price Target
  • IPCALAB Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Apr 31413.451429.9513801385.55
    Apr 113801456.1513671397.75
    Mar 3113411415.651313.51392.25
    Mar 301245132012451296.75
    Mar 271341134912321245.05
  • IPCALAB Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹1,351.29
    30 Day Moving Average₹1,370.46
    50 Day Moving Average₹1,325.16
    100 Day Moving Average₹1,232.18
    200 Day Moving Average₹1,086.5
  • IPCALAB - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue3,1933,156.660.01
    Operating Profit445432.980.03
    Profit Before Tax282258.20.09
    Net Income233188.290.24
  • IPCALAB - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds3,1362,6940.16
    Total Liabilities1,3211,487-0.11
    Total Assets4,4584,1830.07
  • IPCALAB - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity323265.650.22
    Cash from Investing Activity-119-139.9-0.15
    Cash from Financing Activity-130-156.39-0.17
    Net Cash Flow74-30.64-3.42
  • IPCALAB - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.060.05
    Return on Equity0.090.08
    Return on Capital Employed0.090.09
  • IPCALAB - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.03
    3 Year CAGR Growth in Operating Profit-0.16
    3 Year CAGR Growth in EBIDTA-0.14
    3 Year CAGR Growth in Net Income-0.09
    3 Yr CAGR Growth - Diluted EPS-0.09
  • IPCALAB - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.15
    5 Year CAGR Growth in Operating Profit-0.21
    5 Year CAGR Growth in EBIDTA-0.17
    5 Year CAGR Growth in Net Income-0.3
    3 Yr CAGR Growth - Diluted EPS-0.3
  • IPCALAB - Recent News

    keyboard_arrow_down
    NewsBot
    Mar 31 6:53 AM
    Cadila, Ipca gain 4-9% after US allows emergency use of antimalarial drugs for COVID-19
    Moneycontrol
    NewsBot
    Mar 23 12:03 PM
    ICMR recommends use of anti-malaria drug hydroxychloriquine for treating high-risk COVID-19 patients
    Moneycontrol
    NewsBot
    Mar 23 3:33 AM
    Ipca Labs share price surges 12% as USFDA partially lifts import ban for chloroquine
    Moneycontrol
    NewsBot
    Mar 20 3:48 AM
    How off-the-shelf drugs are making Indian pharma firms interested in fight against COVID-19
    Moneycontrol
    NewsBot
    Feb 26 2:18 AM
    Market Headstart: Nifty likely to consolidate around 11,700; NIIT Tech, IPCA top buys
    Moneycontrol
    NewsBot
    Feb 26 2:13 AM
    Hot Stocks: Here are three buy calls for 8-11% returns in the short term
    Moneycontrol
    NewsBot
    Feb 20 5:43 AM
    Buy Ipca Laboratories; target of Rs 1826: Prabhudas Lilladher
    Moneycontrol
    NewsBot
    Feb 14 9:13 AM
    Buy Ipca Laboratories target of Rs 1590: Sharekhan
    Moneycontrol
    NewsBot
    Feb 14 8:43 AM
    Ipca Labs Consolidated December 2019 Net Sales at Rs 1,212.86 crore, up 20.55% Y-o-Y
    Moneycontrol
    NewsBot
    Feb 12 10:03 AM
    Ipca Labs at record close, up 6% on strong Q3 revenue growth
    Moneycontrol
  • IPCALAB - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Dr. Reddy's Laboratories Ltd. Sector...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Piramal Enterprises Ltd. Sector: Phar...
    Divi's Laboratories Ltd. Sector: Pha...
    Glenmark Pharmaceuticals Ltd. Sector...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.